Prognostic Value of Lymph Node Yield and Metastatic Lymph Node Ratio in Medullary Thyroid Carcinoma
- 2 July 2008
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (9) , 2493-2499
Abstract
Lymphadenectomy and thyroidectomy is standard treatment for medullary thyroid carcinoma (MTC), but the prognostic importance of the number of lymph nodes removed (lymph node yield, LNY) and the proportion of metastatic lymph nodes resected (metastatic lymph node ratio, MLNR) is unknown. We hypothesized that MTC survival is influenced by LNY and MLNR. Patients (N = 534) who underwent thyroidectomy with lymphadenectomy for MTC between 1988 and 2004 were identified in the Surveillance, Epidemiology, and End Results (SEER) database. The Kaplan–Meier method was used for univariate comparisons of survival for LNY and MLNR with a maximum follow-up of 12 years. Cox regression models adjusted for age, sex, extent of disease, tumor size, nodal status, LNY, and MLNR. By univariate analysis, increasing LNY was associated with improved survival in all patients (P < 0.002) and node-positive patients (P < 0.001). In a multivariate analysis using LNY and MLNR as categorical variables, significant factors influencing survival included: age (P < 0.001), tumor size (P < 0.001), LNY (P = 0.007), and MLNR (P < 0.02); in node-negative patients: age (P = 0.002); in node-positive patients: age (P < 0.001), tumor size (P < 0.001), and LNY (P = 0.001). Using LNY and MLNR as continuous variables, significant factors influencing survival included: age (P < 0.001), tumor size (P < 0.001), and MLNR (P = 0.01); in node-negative patients: age (P < 0.001); in node-positive patients: age (P < 0.001) and tumor size (P < 0.001). In patients undergoing thyroidectomy and lymphadenectomy for MTC, LNY and MLNR predict poorer survival, but their impact on survival was limited to node-positive patients and was otherwise dominated by the effects of age and extent of disease.Keywords
This publication has 25 references indexed in Scilit:
- Neck management in medullary thyroid carcinomaEuropean Journal of Surgical Oncology, 2008
- Medullary Thyroid Cancer: A Retrospective Analysis of a Cohort Treated at a Single Tertiary Care Center Between 1970 and 2005Thyroid®, 2007
- Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patientsEuropean Journal of Surgical Oncology, 2007
- Initial Lymph Node Dissection Increases Cure Rates in Patients with Medullary Thyroid CancerAsian Journal of Surgery, 2007
- Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: Systemic disease?Surgery, 2006
- Extent of Disease and Practice Patterns for Medullary Thyroid CancerJournal of the American College of Surgeons, 2005
- Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndromeCancer, 2001
- Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996Cancer, 2000
- Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysisCancer, 2000
- Medullary Thyroid Cancer: Analyses of Survival and Prognostic Factors and the Role of Radiation Therapy in Local ControlThyroid®, 1996